Cargando…
Design and Screening of New Lead Compounds for Autism Based on QSAR Model and Molecular Docking Studies
The purpose of the present study aims to develop a satisfactory model for predicting pro-social and pro-cognitive effects on azinesulfonamides of cyclic amine derivatives as potential antipsychotics. The three dimensional-quantitative structure affinity relationship (3D-QSAR) study was performed on...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657114/ https://www.ncbi.nlm.nih.gov/pubmed/36364109 http://dx.doi.org/10.3390/molecules27217285 |
_version_ | 1784829610115989504 |
---|---|
author | Chen, Yongjian Ma, Kang Xu, Peilong Si, Hongzong Duan, Yunbo Zhai, Honglin |
author_facet | Chen, Yongjian Ma, Kang Xu, Peilong Si, Hongzong Duan, Yunbo Zhai, Honglin |
author_sort | Chen, Yongjian |
collection | PubMed |
description | The purpose of the present study aims to develop a satisfactory model for predicting pro-social and pro-cognitive effects on azinesulfonamides of cyclic amine derivatives as potential antipsychotics. The three dimensional-quantitative structure affinity relationship (3D-QSAR) study was performed on a series of azinesulfonamides of cyclic amine derivative using comparative molecular similarity indices analysis (CoMSIA). The best statistical model of CoMSIA q2, r2, SEE and F values are 0.664, 0.973, 0.087, and 82.344, respectively. Based on the model contour maps and the highest activity structure of the 43rd compound, serial new structures were designed and the 43k1 compound was selected as the best structure. The dock results showed a good binding of 43k1 with the protein (PDB ID: 6A93). The QSAR model analysis of the contour maps can help us to provide guidelines for finding novel potential antipsychotics. |
format | Online Article Text |
id | pubmed-9657114 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96571142022-11-15 Design and Screening of New Lead Compounds for Autism Based on QSAR Model and Molecular Docking Studies Chen, Yongjian Ma, Kang Xu, Peilong Si, Hongzong Duan, Yunbo Zhai, Honglin Molecules Article The purpose of the present study aims to develop a satisfactory model for predicting pro-social and pro-cognitive effects on azinesulfonamides of cyclic amine derivatives as potential antipsychotics. The three dimensional-quantitative structure affinity relationship (3D-QSAR) study was performed on a series of azinesulfonamides of cyclic amine derivative using comparative molecular similarity indices analysis (CoMSIA). The best statistical model of CoMSIA q2, r2, SEE and F values are 0.664, 0.973, 0.087, and 82.344, respectively. Based on the model contour maps and the highest activity structure of the 43rd compound, serial new structures were designed and the 43k1 compound was selected as the best structure. The dock results showed a good binding of 43k1 with the protein (PDB ID: 6A93). The QSAR model analysis of the contour maps can help us to provide guidelines for finding novel potential antipsychotics. MDPI 2022-10-26 /pmc/articles/PMC9657114/ /pubmed/36364109 http://dx.doi.org/10.3390/molecules27217285 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Chen, Yongjian Ma, Kang Xu, Peilong Si, Hongzong Duan, Yunbo Zhai, Honglin Design and Screening of New Lead Compounds for Autism Based on QSAR Model and Molecular Docking Studies |
title | Design and Screening of New Lead Compounds for Autism Based on QSAR Model and Molecular Docking Studies |
title_full | Design and Screening of New Lead Compounds for Autism Based on QSAR Model and Molecular Docking Studies |
title_fullStr | Design and Screening of New Lead Compounds for Autism Based on QSAR Model and Molecular Docking Studies |
title_full_unstemmed | Design and Screening of New Lead Compounds for Autism Based on QSAR Model and Molecular Docking Studies |
title_short | Design and Screening of New Lead Compounds for Autism Based on QSAR Model and Molecular Docking Studies |
title_sort | design and screening of new lead compounds for autism based on qsar model and molecular docking studies |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657114/ https://www.ncbi.nlm.nih.gov/pubmed/36364109 http://dx.doi.org/10.3390/molecules27217285 |
work_keys_str_mv | AT chenyongjian designandscreeningofnewleadcompoundsforautismbasedonqsarmodelandmoleculardockingstudies AT makang designandscreeningofnewleadcompoundsforautismbasedonqsarmodelandmoleculardockingstudies AT xupeilong designandscreeningofnewleadcompoundsforautismbasedonqsarmodelandmoleculardockingstudies AT sihongzong designandscreeningofnewleadcompoundsforautismbasedonqsarmodelandmoleculardockingstudies AT duanyunbo designandscreeningofnewleadcompoundsforautismbasedonqsarmodelandmoleculardockingstudies AT zhaihonglin designandscreeningofnewleadcompoundsforautismbasedonqsarmodelandmoleculardockingstudies |